ArticleInflammation2025

A Quinoxaline Derivative as a New Therapeutic Agent for Sepsis through Suppression of TLR4 Signaling Pathways.

Hamza Hanieh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.